Your browser doesn't support javascript.
loading
Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing.
Fulk, Kelly; Milam, Michael R; Li, Shuwei; Yussuf, Amal; Black, Mary Helen; Chao, Elizabeth C; LaDuca, Holly; Stany, Michael P.
Afiliación
  • Fulk K; Ambry Genetics, Aliso Viejo, CA, United States of America. Electronic address: kfulk@ambrygen.com.
  • Milam MR; St Thomas Health, Nashville, TN, United States of America.
  • Li S; Ambry Genetics, Aliso Viejo, CA, United States of America.
  • Yussuf A; Ambry Genetics, Aliso Viejo, CA, United States of America.
  • Black MH; Ambry Genetics, Aliso Viejo, CA, United States of America.
  • Chao EC; Ambry Genetics, Aliso Viejo, CA, United States of America; University of California Irvine, Irvine, CA, United States of America.
  • LaDuca H; St Thomas Health, Nashville, TN, United States of America.
  • Stany MP; St Thomas Health, Nashville, TN, United States of America.
Gynecol Oncol ; 152(3): 612-617, 2019 03.
Article en En | MEDLINE | ID: mdl-30612783
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Neoplasias de la Mama / Mutación de Línea Germinal Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Neoplasias de la Mama / Mutación de Línea Germinal Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article